Follow the Harvard Apparatus Regenerative Technology, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 1 December 2025 (Acquisition). Among the most active insiders: He Junli. All data is accessible without an account.
14
Insider Decl.
n/a
Thresholds
€158,918
14 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Harvard Apparatus Regenerative Technology, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
43Σ signal
Buys €158,918n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,931 of 29,063 companies
14.1
score / 100
Value
23
Quality
6
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn0.0%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
6,864 shares@ US$4.35100.0% of flowCommon StockSEC:0001493152-23-030013:0
Canonical exit: 19 Nov 2023 (T+90)
14 of 14 declarations
Acerca de Harvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology, Inc. es una empresa enfocada en el desarrollo de tecnologías regenerativas para aplicaciones médicas. Su objetivo es crear soluciones innovadoras para la medicina regenerativa.